The authors conducted a comparative study of the structure of consumption of proton pump inhibitors presented in the pharmaceutical market of Ukraine, with an emphasis on the domestic manufacturer. The largest relative increase in esomeprazole in the 1st quarter of 2020 compared to the same period last year is shown.